mbp's new competitor ???????, page-9

What the company thinks is irrelevant. It's up to bodies like the FDA in the US and the TGA here that mandate the standards of trials. There are other issues as well such as manufacture process that could introduce low levels of substances that could have unwanted actions etc etc....

Not saying that I don't think that it has great potential. My money's where my mouth is as I own shares in MBP. Just that I wouldn't necessarily expect the clinical trials process to be significantly shorter than normal.